A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma

Abstract Background Except for B7-CD28 family members, more novel immune checkpoints are being discovered. They are closely associated with tumor immune microenvironment and regulate the function of many immune cells. Various cancer therapeutic studies targeting these novel immune checkpoints are cu...

Full description

Bibliographic Details
Main Authors: Nan Sun, Yuejun Luo, Bo Zheng, Zhihui Zhang, Chaoqi Zhang, Zhen Zhang, Guochao Zhang, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Journal of Translational Medicine
Subjects:
Lung adenocarcinoma
Immune checkpoints
Prognosis
PD-L1
Immunotherapy
Online Access:https://doi.org/10.1186/s12967-022-03520-6

Internet

https://doi.org/10.1186/s12967-022-03520-6

Similar Items